Terminated PHASE1 INTERVENTIONAL 1-arm NCT00427414

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

Pilot Study of Viral Load and Transcription in Kaposi's Sarcoma Patients Treated With Liposomal Anthracyclines

Sponsor: AIDS Malignancy Consortium

Conditions Sarcoma

Interventions liposomal daunorubicin citrate

Updated 7 times since 2017 Last updated: Apr 28, 2015 Started: Sep 30, 2008 Primary completion: Nov 30, 2010 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated due to slow accrual.

Other terminated trials from AIDS Malignancy Consortium

See all terminations from AIDS Malignancy Consortium

Other Sarcoma trials with similar outcome

Browse all Sarcoma trials

A PHASE1 clinical study on Sarcoma, this trial is terminated or withdrawn. The trial is conducted by AIDS Malignancy Consortium and has accumulated 7 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE1
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2019 — Jan 2021 [monthly]

Terminated PHASE1

▶ Show 2 earlier versions

Jun 2018 — Jun 2019 [monthly]

Terminated PHASE1
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AIDS Malignancy Consortium
National Cancer Institute (NCI)
The Emmes Company, LLC

Data source: AIDS Malignancy Consortium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cerqueira Cesar - Sao Paulo/SP, Brazil
• Miami, United States
• São Paulo, Brazil